Current and Future Pharmacological Treatment Strategies in X‐Linked Adrenoleukodystrophy

Mutations in the ABCD1 gene cause the clinical spectrum of the neurometabolic disorder X‐linked adrenoleukodystrophy/adrenomyeloneuropathy (X‐ALD/AMN). Currently, the most efficient therapeutic opportunity for patients with the cerebral form of X‐ALD is hematopoietic stem cell transplantation and po...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Berger, Johannes, Pujol, Aurora, Aubourg, Patrick, Forss‐Petter, Sonja
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Publishing Ltd 2010
Gaiak:
MINI‐SYMPOSIUM: X‐Linked Adrenoleukodystrophy
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2967711/
https://ncbi.nlm.nih.gov/pubmed/20626746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1750-3639.2010.00393.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak